pyrazinamide and rifamycins

pyrazinamide has been researched along with rifamycins in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (31.25)	18.7374
1990's	2 (12.50)	18.2507
2000's	2 (12.50)	29.6817
2010's	6 (37.50)	24.3611
2020's	1 (6.25)	2.80

Authors

Authors	Studies
Iusukhno, EE; Khomenko, VV; Petrovich, DI; Porokhnia, VV; Skvira, VP	1
Cynamon, MH; Grossi, MA; Klemens, SP	1
Chase, SE; Chmielewski, AJ; Cynamon, MH; Lenaerts, AM	1
Chase, SE; Cynamon, MH; Lenaerts, AM	1
HURNI, H	1
COMENALE, D; FILLA, E; ROSSI, F	1
Azeeza, S; Kamal, A; Malik, MS; Rao, MV; Shaik, AA	1
Grosset, J; Leung, CC; Yew, WW	1
Alsultan, A; Belchis, DA; Dutta, NK; Gniadek, TJ; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Pinn, ML	1
Heysell, SK; Reynolds, J	1
Cole, ST; Dhar, N; Hartkoorn, RC; Lechartier, B; Sala, C; Vocat, A; Zhang, M	1
Barry, CE; Blanc, L; Boshoff, H; Dartois, VA; Eugenin, EA; Sarathy, JP; Via, LE; Weiner, D	1
Kammara, R; Lokesh, D; Parkesh, R	1
Alameer, R; Almaghrabi, RS; Almohaizeie, A; Alrajhi, AA; Alshehri, N; Nizami, I; Omrani, AS	1

Reviews

2 review(s) available for pyrazinamide and rifamycins

Article	Year
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2008, Sep-09, Volume: 11, Issue:2 Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary	2008
Understanding pharmacokinetics to improve tuberculosis treatment outcome. Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:6 Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary	2014

Article

Year

Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2008, Sep-09, Volume: 11, Issue:2

Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary

2008

Understanding pharmacokinetics to improve tuberculosis treatment outcome.

Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:6

Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary

2014

Trials

2 trial(s) available for pyrazinamide and rifamycins

Article	Year
Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study. The American review of respiratory disease, 1976, Volume: 114, Issue:3 Topics: Adolescent; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary	1976
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet (London, England), 1973, Jun-16, Volume: 1, Issue:7816 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifamycins; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary	1973

Article

Year

Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.

The American review of respiratory disease, 1976, Volume: 114, Issue:3

Topics: Adolescent; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary

1976

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.

Lancet (London, England), 1973, Jun-16, Volume: 1, Issue:7816

Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifamycins; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary

1973

Other Studies

12 other study(ies) available for pyrazinamide and rifamycins

Article	Year
[Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis]. Problemy tuberkuleza, 1989, Issue:3 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary	1989
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10 Topics: Animals; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; Isoniazid; Mice; Pyrazinamide; Rifabutin; Rifampin; Rifamycins; Tuberculosis	1994
Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:10 Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis	1999
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:11 Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis	2000
[On new tuberculostatic agents]. Wiener klinische Wochenschrift, 1963, Mar-08, Volume: 75 Topics: Anilides; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifamycins	1963
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM]. Minerva medica, 1964, Aug-18, Volume: 55 Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabolism; Cycloserine; Diabetes Mellitus; Drug Tolerance; Ethionamide; Humans; Isoniazid; Kanamycin; Pharmacology; Pyrazinamide; Rifamycins; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary	1964
Harnessing the full sterilising activity of rifamycins. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011, Volume: 15, Issue:4 Topics: Animals; Antitubercular Agents; Drug Design; Humans; Pyrazinamide; Rifampin; Rifamycins; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary	2011
Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Animals; Antitubercular Agents; Area Under Curve; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Guinea Pigs; Lung; Mycobacterium tuberculosis; Nitroimidazoles; Organ Size; Pyrazinamide; Recurrence; Rifamycins; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Adamantane; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Discovery; Ethylenediamines; Genes, Bacterial; Luminescence; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Photorhabdus; Pyrazinamide; Rifamycins; Xanthenes	2015
Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Animals; Antitubercular Agents; Drug Tolerance; Mycobacterium tuberculosis; Pyrazinamide; Rabbits; Rifamycins; Tuberculosis	2018
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs. Scientific reports, 2018, 08-09, Volume: 8, Issue:1 Topics: Antitubercular Agents; Bacterial Proteins; Bifidobacterium adolescentis; Binding Sites; Drug Resistance, Multiple, Bacterial; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Protein Binding; Protein Domains; Pyrazinamide; Rifamycins; RNA Polymerase II	2018
Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2021, Volume: 19, Issue:4 Topics: Ethambutol; Humans; Isoniazid; Lung; Lung Transplantation; Moxifloxacin; Pyrazinamide; Rifamycins; Transplant Recipients; Treatment Outcome; Tuberculosis	2021